Redox metabolism: ROS as specific molecular regulators of cell signaling and function
Planning your 100mg protocol Now let's put everything together into practical protocol planning
This kind of trial is expensive typically several million dollars and to date has been more difficult to justify economically because GHK-Cu cannot be patented as a novel drug (the molecule is endogenous and the relevant patents have expired)
Targets Inflammation: Free radicals are reactive molecules that can damage cells and tissues, leading to inflammation
Tang L, Yu F, Tang B, Yang Z, Fan W, Zhang M, et al
By binding two GHK molecules to each copper ion, the reactivity decreases while maintaining biological activity